Inebilizumab, CAS 1299440-37-1

Product Description: Inebilizumab is an anti-CD19 monoclonal antibody (mAb) with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used for multiple sclerosis and neuromyelitis optica research[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Chen D, et al. Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies. J Clin Med. 2016 Nov 24;5(12):107./[2]Herbst R, et al. B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody. J Pharmacol Exp Ther. 2010 Oct;335(1):213-22.

CAS Number: 1299440-37-1

Molecular Weight: N/A

Compound Purity: 98.83

Research Area: Inflammation/Immunology

Solubility: H2O

Target: ADC Antibody;CD19

• Artikelnummer: MEXHY-P99113-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99113-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK